These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 8591951)
1. High frequency of mutations at codon 83 of the gyrA gene of quinolone-resistant clinical isolates of Escherichia coli. Ruiz J; Marco F; Goñi P; Gallardo F; Mensa J; Trilla A; Jimenez de Anta T; Vila J J Antimicrob Chemother; 1995 Oct; 36(4):737-8. PubMed ID: 8591951 [No Abstract] [Full Text] [Related]
2. Molecular epidemiology and mutations at gyrA and parC genes of ciprofloxacin-resistant Escherichia coli isolates from a Taiwan medical center. Chen JY; Siu LK; Chen YH; Lu PL; Ho M; Peng CF Microb Drug Resist; 2001; 7(1):47-53. PubMed ID: 11310803 [TBL] [Abstract][Full Text] [Related]
3. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance. Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005 [TBL] [Abstract][Full Text] [Related]
4. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Yoshida H; Bogaki M; Nakamura M; Nakamura S Antimicrob Agents Chemother; 1990 Jun; 34(6):1271-2. PubMed ID: 2168148 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the NH2-terminal 83rd amino acid of Escherichia coli GyrA in quinolone-resistance. Yonezawa M; Takahata M; Banzawa N; Matsubara N; Watanabe Y; Narita H Microbiol Immunol; 1995; 39(4):243-7. PubMed ID: 7651238 [TBL] [Abstract][Full Text] [Related]
6. Mutation in the DNA gyrase A Gene of Escherichia coli that expands the quinolone resistance-determining region. Friedman SM; Lu T; Drlica K Antimicrob Agents Chemother; 2001 Aug; 45(8):2378-80. PubMed ID: 11451702 [TBL] [Abstract][Full Text] [Related]
7. Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections. Ozeki S; Deguchi T; Yasuda M; Nakano M; Kawamura T; Nishino Y; Kawada Y J Clin Microbiol; 1997 Sep; 35(9):2315-9. PubMed ID: 9276409 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the NH2-terminal 87th amino acid of Escherichia coli GyrA in quinolone-resistance. Yonezawa M; Takahata M; Banzawa N; Matsubara N; Watanabe Y; Narita H Microbiol Immunol; 1995; 39(7):517-20. PubMed ID: 8569537 [TBL] [Abstract][Full Text] [Related]
9. Characterization of fluoroquinolone resistance among veterinary isolates of avian Escherichia coli. White DG; Piddock LJ; Maurer JJ; Zhao S; Ricci V; Thayer SG Antimicrob Agents Chemother; 2000 Oct; 44(10):2897-9. PubMed ID: 10991884 [TBL] [Abstract][Full Text] [Related]
10. Occurrence of single-point gyrA mutations among ciprofloxacin-susceptible Escherichia coli isolates causing urinary tract infections in Latin America. Gales AC; Gordon KA; Wilke WW; Pfaller MA; Jones RN Diagn Microbiol Infect Dis; 2000 Jan; 36(1):61-4. PubMed ID: 10744370 [TBL] [Abstract][Full Text] [Related]
11. Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene. Kumagai Y; Kato JI; Hoshino K; Akasaka T; Sato K; Ikeda H Antimicrob Agents Chemother; 1996 Mar; 40(3):710-14. PubMed ID: 8851598 [TBL] [Abstract][Full Text] [Related]
13. Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR. Rahman M; Mauff G; Levy J; Couturier M; Pulverer G; Glasdorff N; Butzler JP Antimicrob Agents Chemother; 1994 Oct; 38(10):2488-91. PubMed ID: 7840594 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates. Tavío MM; Vila J; Ruiz J; Ruiz J; Martín-Sánchez AM; Jiménez de Anta MT J Antimicrob Chemother; 1999 Dec; 44(6):735-42. PubMed ID: 10590273 [TBL] [Abstract][Full Text] [Related]
15. Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa. Yoshida H; Nakamura M; Bogaki M; Nakamura S Antimicrob Agents Chemother; 1990 Jun; 34(6):1273-5. PubMed ID: 2168149 [TBL] [Abstract][Full Text] [Related]
16. Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli. Bagel S; Hüllen V; Wiedemann B; Heisig P Antimicrob Agents Chemother; 1999 Apr; 43(4):868-75. PubMed ID: 10103193 [TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiological analysis of quinolone-resistant Escherichia coli causing bacteremia in neutropenic patients with leukemia in Korea. Yoo JH; Huh DH; Choi JH; Shin WS; Kang MW; Kim CC; Kim DJ Clin Infect Dis; 1997 Dec; 25(6):1385-91. PubMed ID: 9431383 [TBL] [Abstract][Full Text] [Related]
18. In vitro plasmid-encoded resistance to quinolones. Gómez-Gómez JM; Blázquez J; Espinosa De Los Monteros LE; Baquero MR; Baquero F; Martínez JL FEMS Microbiol Lett; 1997 Sep; 154(2):271-6. PubMed ID: 9311124 [TBL] [Abstract][Full Text] [Related]
19. Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV associated with quinolone resistance in Enterococcus faecalis. Kanematsu E; Deguchi T; Yasuda M; Kawamura T; Nishino Y; Kawada Y Antimicrob Agents Chemother; 1998 Feb; 42(2):433-5. PubMed ID: 9527801 [TBL] [Abstract][Full Text] [Related]
20. Analysis of mutations to gyrA in quinolone-resistant clinical isolates of Enterobacter cloacae. Dekitsch C; Schein R; Markopulos E; Kuen B; Graninger W; Georgopoulos A J Med Microbiol; 1999 Jan; 48(1):73-77. PubMed ID: 9920128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]